Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Current Taxes (2016 - 2026)

Pharma-Bio Serv's Current Taxes history spans 16 years, with the latest figure at $722104.0 for Q1 2026.

  • For Q1 2026, Current Taxes rose 21.36% year-over-year to $722104.0; the TTM value through Jan 2026 reached $722104.0, up 21.36%, while the annual FY2025 figure was $718796.0, 20.95% up from the prior year.
  • Current Taxes reached $722104.0 in Q1 2026 per PBSV's latest filing, roughly flat from $718796.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.9 million in Q1 2022 to a low of $337264.0 in Q4 2022.
  • Average Current Taxes over 5 years is $824566.1, with a median of $713153.0 recorded in 2025.
  • Peak YoY movement for Current Taxes: tumbled 73.59% in 2023, then surged 61.72% in 2024.
  • A 5-year view of Current Taxes shows it stood at $337264.0 in 2022, then soared by 58.27% to $533782.0 in 2023, then increased by 11.34% to $594316.0 in 2024, then increased by 20.95% to $718796.0 in 2025, then rose by 0.46% to $722104.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Current Taxes are $722104.0 (Q1 2026), $718796.0 (Q4 2025), and $713153.0 (Q3 2025).